Mallinckrodt Public Ltd Co, Inc (MNK) Covered Calls

Mallinckrodt Public Ltd Co, Inc covered calls Mallinckrodt PLC develops, manufactures, markets and distributes specialty pharmaceutical products and diagnostic imaging agents. Its specialty pharmaceutical products are sold to wholesalers and retail drugstore chains.

You can sell covered calls on Mallinckrodt Public Ltd Co, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for MNK (prices last updated Wed 4:16 PM ET):

Mallinckrodt Public Ltd Co, Inc (MNK) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
18.20 -0.16 18.00 19.50 1.2M 1.2 1.5B
Covered Calls For Mallinckrodt Public Ltd Co, Inc (MNK)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
May 17 18 1.45 18.05 -0.3% -4.6%
Jun 21 18 1.85 17.65 2.0% 12.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. The company operates its business through two segments: Specialty Pharmaceuticals and Global Medical Imaging. The Specialty Pharmaceuticals segment produces and markets branded pharmaceuticals and biopharmaceuticals, specialty generic pharmaceuticals and active pharmaceutical ingredients consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. The Global Medical Imaging segment develops, manufactures and markets contrast media and delivery systems and radiopharmaceuticals. Mallinckrodt was founded on January 9, 2013 and is headquartered in Dublin, Ireland.